The obvious point for a display of great excitemen
Post# of 148279
And thus the obvious conclusion is that if a 3rd and 4th dose been "allowed" and given after day 12 or 14, we'd have an EUA today, maybe full approval and a stock price at $20. And some of our friends who are dead, would be alive.
Will the 82% reduction generate excitement and optimism in a population of investors that have been waiting and waiting for covid-19 and for HIV, cancer, NASH and who've been kicked around by shorts and hedge funds for a year, who are now told, "another trial, wait 10 to 12 more weeks"?
I think for most investors it's like "ok, I'll wait since there's still no treatment for critical cv19 patients, and the science has now truly been confirmed with data.
But if this is the boldest news on Tuesday, I don't think it's enough to spark a substantial rise is share price. Foreign purchases or approvals are needed.